TrialAdvances in therapy2024

Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP).

Raphael Schiffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.